Skip to main content
Screener/Healthcare/Biotechnology

SYRE — Spyre Therapeutics, Inc.

NASDAQ
$104.67+1.23 (+1.19%)
Mid CapHealthcareHigh Beta
$14.51
$108.14
$103.64
$106.67
EPS (TTM)$-2.19
P/E Ratio-153.02
Dividend Yield—
Market Cap$8.98B
Volume341K
Prev Close$103.42
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$69.0M$-0.74——
Q4 '25$90.5M-$62.5M$-0.7050.0%-69.1%
Q3 '25$0-$11.2M$-0.15——
Q2 '25$0-$36.7M$-0.60——
Q1 '25$0-$44.8M$-0.13——
Q4 '24$0-$56.3M$-0.15——
Q3 '24$0-$69.0M$-1.36——
Q2 '24$0-$38.8M$-0.86——
Get Your Daily Market Recap
SYRE Stock Price, Chart & Analysis